Physician profile
John Robert Larson
NPI 1104864354
$1,490.36
in general payments reported to CMS, 2019-2025
18 companies · $687 in 2025
The $687 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $159 · 2021: $68.27 · 2022: $94.96 · 2023: $75.74 · 2024: $68.37 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $300 · Food and Beverage: $296 · Travel and Lodging: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $300.00 |
| Food and Beverage | $295.78 |
| Travel and Lodging | $235.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $648.65 | 2019-2025 | Prialt |
| Spinal Simplicity, LLC | $261.25 | 2025 | Ha Minuteman G3-R |
| Pacira Therapeutics, INC. | $176.75 | 2019 | |
| Abbvie INC. | $83.90 | 2024-2025 | |
| Medtronic USA, INC. | $69.30 | 2020 | |
| Allergan, INC. | $40.37 | 2019-2020 | |
| Nalu Medical, INC. | $33.72 | 2022 | |
| Stryker Corporation | $23.96 | 2020 | |
| Boston Scientific Corporation | $23.00 | 2025 | Wavewriter Alpha Prime 16 |
| Averitas Pharma INC. | $22.18 | 2024 | Qutenza |
| Redhill Biopharma INC. | $19.41 | 2021 | |
| Radius Health, INC. | $17.87 | 2021 | |
| Grt US Holding, INC. | $17.00 | 2022 | |
| Nevro Corp. | $14.24 | 2020 | |
| Pfizer INC. | $11.53 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $11.15 | 2020 | |
| Daiichi Sankyo INC. | $11.13 | 2019 | |
| Kinex Medical Company LLC | $4.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.